Epoxomicin, A New Antitumor Agent of Microbial Origin

205Citations
Citations of this article
79Readers
Mendeley users who have this article in their library.

Abstract

An actinomycete strain No. Q996-17 produced a novel compound, epoxomicin, which exhibited in vivo antitumor activity against B16 melanoma. Structural studies indicated that it is a new member of the epoxy-β-aminoketone group, and is closely related to eponemycin. © 1992, JAPAN ANTIBIOTICS RESEARCH ASSOCIATION. All rights reserved.

Cite

CITATION STYLE

APA

Hanada, M., Sugawara, K., Kaneta, K., Toda, S., Nishiyama, Y., Tomita, K., … Oki, T. (1992). Epoxomicin, A New Antitumor Agent of Microbial Origin. The Journal of Antibiotics, 45(11), 1746–1752. https://doi.org/10.7164/antibiotics.45.1746

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free